Title: The U.S.-China trade agreement—a huge deal for China
Headings: The U.S.-China trade agreement—a huge deal for China
The U.S.-China trade agreement—a huge deal for China
Joshua P. Meltzer
Senior Fellow - Global Economy and Development
The U.S.-China Trade Agreement
The One Belt One Road Initiative
One Belt, One Road and the Trans-Pacific Partnership
In part, OBOR was China’s response to the U.S.-led TPP.
The Strategic Consequences of the U.S-China Trade Agreement
Order from Chaos

Content: The U.S.-China trade agreement—a huge deal for China
Series: Trump and Asia Watch
Order from Chaos
The U.S.-China trade agreement—a huge deal for China
Joshua P. Meltzer Monday, May 15, 2017
Order from Chaos
Facebook Click to share on Facebook
Twitter Click to share on Twitter
LinkedIn Click to share on LinkedIn
Print Click to print
SMS Click to share on SMS
Email Click to email this to a friend
Reddit Click to share on Reddit
More
The United States’ recognition of the importance of China’s One Belt, One Road (OBOR) initiative as part of the May 11 U.S.-China Trade Agreement is an important economic and diplomatic win for China. Such recognition signals U.S. acceptance of China’s ambition to expand its regional leadership and influence. U.S. recognition of OBOR adds to uncertainty over the Trump administration’s commitment to economic leadership in Asia as a result of President Donald Trump’s decision to pull the United States out of the 12-nation Trans Pacific Partnership (TPP) trade agreement. Joshua P. Meltzer
Senior Fellow - Global Economy and Development
Twitter
@JoshuaPMeltzer
The U.S.-China Trade Agreement
The U.S.-China trade agreement could lead to worthwhile new market access for U.S. exports to China. In particular, U.S. beef exports to China will resume, and there are commitments to expand access for a range of U.S. financial services and biotech products and to reduce regulation on U.S. exports of liquefied natural gas to China. The United States agreed to accept imports from China of cooked chicken. The deal gives some substance to the agreement by Trump and Chinese President Xi Jinping at their April meeting to develop a 100-day trade plan. However, as the gains for finance and biotech depend on follow-through by China’s regulatory agencies, the actual impact remains to be seen. As has been the case with previous Chinese trade and investment commitments, there are often gaps between the promise and its implementation.